These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12144897)

  • 21. Targeted inhibition of angiogenic factors in AIDS-related disorders.
    Aoki Y; Tosato G
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KSHV/HHV8-associated lymphomas.
    Carbone A; Gloghini A
    Br J Haematol; 2008 Jan; 140(1):13-24. PubMed ID: 17991301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
    Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
    J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virokines in the pathogenesis of cancer: focus on human herpesvirus 8.
    Klouche M; Carruba G; Castagnetta L; Rose-John S
    Ann N Y Acad Sci; 2004 Dec; 1028():329-39. PubMed ID: 15650258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and manifestations of human herpesvirus-8-associated disorders.
    Aoki Y; Tosato G
    Semin Hematol; 2003 Apr; 40(2):143-53. PubMed ID: 12704591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary effusion lymphoma with subsequent development of a small bowel mass in an HIV-seropositive patient: a case report and literature review.
    Huang Q; Chang KL; Gaal K; Arber DA
    Am J Surg Pathol; 2002 Oct; 26(10):1363-7. PubMed ID: 12360052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient.
    Ozbalak M; Tokatlı I; Özdemirli M; Tecimer T; Ar MC; Örnek S; Koroglu A; Laleli Y; Ferhanoglu B
    Eur J Haematol; 2013 Nov; 91(5):467-9. PubMed ID: 23865480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas).
    Drexler HG; Uphoff CC; Gaidano G; Carbone A
    Leukemia; 1998 Oct; 12(10):1507-17. PubMed ID: 9766492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.
    Gaidano G; Castaños-Velez E; Biberfeld P
    Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
    Alkaied H; Harris K; Elsayegh D; Khachaturova I; Awasum M; Varma S
    Med Oncol; 2012 Jun; 29(2):1109-13. PubMed ID: 21472488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
    Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
    Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
    Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
    Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human herpesvirus 8: is it a tumor virus?
    Neipel F; Albrecht JC; Fleckenstein B
    Proc Assoc Am Physicians; 1999; 111(6):594-601. PubMed ID: 10591089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases.
    Humphrey RW; Davis DA; Newcomb FM; Yarchoan R
    Leuk Lymphoma; 1998 Jan; 28(3-4):255-64. PubMed ID: 9517497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human herpes virus 8: a new virus discloses its face.
    Cathomas G
    Virchows Arch; 2000 Mar; 436(3):195-206. PubMed ID: 10782877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.